Format

Send to

Choose Destination
Surg Oncol. 2002 Jun;11(1-2):35-45.

Advances in prostate cancer immunotherapy.

Author information

1
Department of Urology, St. George's Hospital Medical School, London SW17 0RE, UK.

Abstract

Metastatic prostate cancer remains incurable. Harnessing the body's own immune system to control or eradicate tumours has long been an attractive concept. Only recently has the field of tumour immunology provided the basic science behind the mechanisms of tumour genesis, molecular basis of the recognition of tumour associated antigens and the interactions of the antigen-presenting cells with effector cells. This research has been translated into numerous clinical immunotherapy strategies, which have reached the oncology clinic and which should provide options for our patients.

PMID:
12031866
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center